Thomas P Stricker (Thomas Stricker)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Early Breast Cancer

Endoplasmic Reticulum

Epidermal Growth Factor Receptor

Top Venues

Cancer medicine

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew L Sochacki, Cosmin A Bejan, Shilin Zhao, Ameet Patel, Ashwin Kishtagari, Travis P Spaulding, Alexander James Silver, Shannon S Stockton, Kelly Pugh, Rodney Dixon Dorand, Manasa Ram Bhatta, Nicholas Strayer, Siwei Zhang, Christina A Snider, Thomas P Stricker, Aziz Nazha, Alexander G Bick, Yaomin Xu, Michael R Savona
Patient-specific comorbidities as prognostic variables for survival in myelofibrosis. Blood advances (2022)
Kimberly M Stauffer, David L Elion, Rebecca S Cook, Thomas P Stricker
MLL3 is a de novo cause of endocrine therapy resistance. Cancer medicine 10 (21) (2021)
Jennifer M Giltnane, Katherine E Hutchinson, Thomas P Stricker, Luigi Formisano, Christian D Young, M Valeria Estrada, Mellissa J Nixon, Liping Du, Violeta Sanchez, Paula I Gonzalez Ericsson, Maria G Kuba, Melinda E Sanders, Xinmeng Jasmine Mu, Eliezer Van Allen, Nikhil Wagle, Ingrid A Mayer, Vandana Abramson, Henry Gόmez, Monica Rizzo, Weiyi Toy, Sarat Chandarlapaty, Erica L Mayer, Jason Christiansen, Danielle A Murphy, Kerry Fitzgerald, Kai Wang, Jeffery S Ross, Vincent A Miller, Phillip J Stephens, Roman Yelensky, Levi Garraway, Yu Shyr, Ingrid Meszoely, Justin M Balko, Carlos L Arteaga
Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance. Science translational medicine 9 (402) (2018)